Barclays PLC Global Blood Therapeutics, Inc. Put Options Transaction History

Barclays PLC

12 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2020 Feb 11, 2021	BUY	$37.65 - $63.77 $1.47 Million - $2.49 Million	39,100 Added 4344.44%	40,000 $1.73 Million
Q1 2020 May 13, 2020	SELL	$41.72 - $87.2 $16,688 - $34,880	-400 Reduced 30.77%	900 $46,000
Q4 2019 Feb 10, 2020	BUY	$45.7 - $81.86 $4,570 - $8,186	100 Added 8.33%	1,300 $103,000
Q3 2019 Nov 14, 2019	SELL	$45.35 - $57.91 $226,750 - $289,550	-5,000 Reduced 80.65%	1,200 $58,000
Q2 2019 Aug 14, 2019	BUY	$52.6 - $63.29 $263,000 - $316,450	5,000 Added 416.67%	6,200 $326,000
Q1 2019 May 15, 2019	SELL	$39.99 - $53.48 $159,960 - $213,920	-4,000 Reduced 76.92%	1,200 $64,000
Q4 2018 Feb 14, 2019	SELL	$31.54 - $46.67 $2.31 Million - $3.42 Million	-73,200 Reduced 93.37%	5,200 $213,000
Q3 2018 Nov 14, 2018	SELL	$38.0 - $51.1 $581,400 - $781,830	-15,300 Reduced 16.33%	78,400 $2.98 Million
Q2 2018 Aug 14, 2018	BUY	$38.7 - $50.15 $3.62 Million - $4.69 Million	93,500 Added 46750.0%	93,700 $4.24 Million
Q1 2018 May 15, 2018	SELL	$39.6 - $65.9 $7,920 - $13,180	-200 Reduced 50.0%	200 $10,000
Q4 2017 Feb 14, 2018	BUY	$29.7 - $45.7 $5,940 - $9,140	200 Added 100.0%	400 $16,000
Q3 2017 Nov 14, 2017	BUY	$25.1 - $31.05 $5,020 - $6,210	200	200 $6,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.